03122 2200445 4500001002100000005001500021035002000036007000300056008003900059020002200098100013700120245046400257260004500721300002900766700003500795700002600830504002600856040001200882090002300894850001200917852001200929999002300941505008700964505009701051505008401148505011701232505013201349505011601481505014101597505008201738505010901820505011701929505012502046505012402171505008802295505008502383505009102468505010402559990001302663INLIS00000000001998320170922103905 a0010-0917000361ta170922 | | |  a978-602-71520-7-6 aPusat Diabetes dan Nutrisi departemen -SMF Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Airlangga -RSUD. Dr. Soetomo Surabaya1 aProceeding the Quadruple Joint Symposium-2016 :bSurabaya Metabolic Syndrome update (SUMETSU) Metabolic Cardiovascular Disease Surabaya Update (MECARSU) Surabaya Obesity Update (SOBU) Surabaya Diabetes Update (SDU) Cardiometabolic Health Toward - 2020 Challenges in prevention and Treatment of Obesity,MetS,CMR,and the CMDs /cPusat Diabetes dan Nutrisi departemen -SMF Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Airlangga -RSUD. Dr. Soetomo Surabaya aSurabaya :bUniversitas Airlangga,c2016 a142 hlm :bilus ;c25 cm0 aEditor; Askandar Tjokroprawiro0 aEditor; Agung Pranoto aBibliografi : Hlm 142 aJIPDSUR aCB[G]-D13/2016-319 aJIPDSUR aJIPDSUR aCB[G]-D13/2016-319 a1. Deregulated Nutrient - Sensing Pathways in Metabolic Disease / Andi Widjaja / 1 a2. Victoza : Preliminary Clinical Experiences in Daily Practice / Askandar Tjokroprawiro / 2 a3. Astaxanthin in Clinical Practice (Diabetologist View) / Harsinen Sanusi / 17 a4. Bringing RCTs into Real Life Setting : Proving Consistent Efficacy in T2DM Management / Sarwono Waspadji / 29 a5. Beneficial Effects of DPP-4 Inhibitors in the treatment of Type 2 Diabetes (Selective Competitive Linagliptin) /Darmono / 33 a6. Building Together : Clinical use of Linagliptin and Metformin early Combination / Askandar Tjokroprawiro /42 a7. The Healthy food life to postpone healthty life expectancy and to prevent Mets- Eating pattern is important / Naemi M. Kajiwara / 52 a8. Painful Diabetic Neuropathy How to assess and Manage it / Asman Manaf / 57 a9. Should SU Remain an Acceptable 1st Line Add-on to Metformin Therapy in type-2 Diabtes / Em Yunir / 67 a10. Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) Cardiovascular safety / soebagijo Adi / 68 a11. Understanding The Role of Kidney in Glucose Balance Through Renal Sodium Glucose Co-Transporter / Agung Pranoto / 79 a12. Initiation and Titration of Basal Insulin in Type 2 Diabetes Mellitus Focus on Insulin Glargine / John MF Adam / 87 a13. Benefits of Once Daily use of insulin Detemir in type 2 DM / Soebagijo Adi / 96 a14. Berbagai Tipe Stent : Fokus pada apsien Diabetes Mellitus / Idrus Alwi / 113 a15. Metformin : Beyond Glycaemic Control / Soebagijo Adi, Askandar Tjokroprawiro / 125 a16. Role of Pregabalin on Painful Diabetic Neuropathy (Evidence Based Review) / Sony Wibisono / 138 aDPK12215